248 related articles for article (PubMed ID: 19233065)
1. Emerging challenges of anemia management in CKD.
Kovesdy CP; Kalantar-Zadeh K
Adv Chronic Kidney Dis; 2009 Mar; 16(2):74-5. PubMed ID: 19233065
[No Abstract] [Full Text] [Related]
2. Hyporesponsiveness to erythropoiesis stimulating agents in chronic kidney disease: the many faces of inflammation.
Adamson JW
Adv Chronic Kidney Dis; 2009 Mar; 16(2):76-82. PubMed ID: 19233066
[TBL] [Abstract][Full Text] [Related]
3. Updating practices in an evolving IV iron and anemia environment: practical solutions.
Amerling R; Easom A; Juergensen P
Nephrol Nurs J; 2007; 34(5):533-41; quiz 542-3. PubMed ID: 18041456
[TBL] [Abstract][Full Text] [Related]
4. Anemia and iron management.
Besarab A
Semin Dial; 2011; 24(5):498-503. PubMed ID: 21906169
[No Abstract] [Full Text] [Related]
5. More than a decade of experience and still no consensus: controversies in iron therapy.
Besarab A
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S1-3. PubMed ID: 17699371
[No Abstract] [Full Text] [Related]
6. Management of anemia in heart failure.
Stamos TD; Silver MA
Curr Opin Cardiol; 2010 Mar; 25(2):148-54. PubMed ID: 19996965
[TBL] [Abstract][Full Text] [Related]
7. The new age of iron: evaluation and management of iron-restricted erythropoiesis.
Goodnough LT
Semin Hematol; 2009 Oct; 46(4):325-7. PubMed ID: 19786200
[No Abstract] [Full Text] [Related]
8. Supporting epoetin alfa stimulated erythropoiesis: identifying appropriate iron levels: case study of the anemic patient.
Sasak C
Nephrol Nurs J; 2000 Dec; 27(6):612-5. PubMed ID: 16649342
[TBL] [Abstract][Full Text] [Related]
9. Current and upcoming erythropoiesis-stimulating agents, iron products, and other novel anemia medications.
Macdougall IC; Ashenden M
Adv Chronic Kidney Dis; 2009 Mar; 16(2):117-30. PubMed ID: 19233071
[TBL] [Abstract][Full Text] [Related]
10. Balance of Benefit and Risk in Intravenous Iron Treatment in Chronic Kidney Disease.
Fishbane S
Semin Nephrol; 2016 Mar; 36(2):119-23. PubMed ID: 27236133
[TBL] [Abstract][Full Text] [Related]
11. Anemia management in chronic kidney disease: intravenous iron steps forward.
Coyne DW; Auerbach M
Am J Hematol; 2010 May; 85(5):311-2. PubMed ID: 20232350
[No Abstract] [Full Text] [Related]
12. Intravenous iron versus erythropoiesis-stimulating agents: friends or foes in treating chronic kidney disease anemia?
Kalantar-Zadeh K; Streja E; Miller JE; Nissenson AR
Adv Chronic Kidney Dis; 2009 Mar; 16(2):143-51. PubMed ID: 19233073
[TBL] [Abstract][Full Text] [Related]
13. [Management of renal anemia in patients with chronic kidney disease: the role of the general practitioner].
Ruedin P; Dickenmann M; Martin PY; Wüthrich RP
Rev Med Suisse; 2012 Jan; 8(323):70-3. PubMed ID: 22303745
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous iron in the current clinical practice.
Beneitez Pastor D
Med Clin (Barc); 2018 Mar; 150(5):188-190. PubMed ID: 28662885
[No Abstract] [Full Text] [Related]
15. Intravenous iron therapy in end-stage renal disease.
Brewster UC
Semin Dial; 2006; 19(4):285-90. PubMed ID: 16893405
[TBL] [Abstract][Full Text] [Related]
16. Hepcidin for clinicians.
Young B; Zaritsky J
Clin J Am Soc Nephrol; 2009 Aug; 4(8):1384-7. PubMed ID: 19556376
[TBL] [Abstract][Full Text] [Related]
17. Hemoglobin control, ESA resistance, and regular low-dose IV iron therapy: a review of the evidence.
Singh A
Semin Dial; 2009; 22(1):64-9. PubMed ID: 19175537
[TBL] [Abstract][Full Text] [Related]
18. Iron replacement therapy in cancer-related anemia: introduction.
Baribeault D; Auerbach M
Am J Health Syst Pharm; 2011 May; 68(10 Suppl 1):S2-3. PubMed ID: 21543774
[No Abstract] [Full Text] [Related]
19. Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?
Pagourelias ED; Koumaras C; Kakafika AI; Tziomalos K; Zorou PG; Athyros VG; Karagiannis A
Angiology; 2009; 60(1):74-81. PubMed ID: 18413330
[TBL] [Abstract][Full Text] [Related]
20. Parenteral iron supplementation in patients with end stage renal disease.
Vogel SC
ANNA J; 1998 Dec; 25(6):625-30. PubMed ID: 10188399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
